does glp-1 help with insulin resistance Receptor Agonists as Treatments for Type 2 Diabetes Your Body Isn't Broken: How
Description
Suicidality and neuropsychiatric risk Reports of suicidality associated with GLP1RA use have raised considerable concern, particularly amid widespread offlabel prescribing for weight loss
23 He, F.F
July 2024: Roche reported early clinical data for CT-996, its once-daily oral GLP-1 receptor agonist, showing clinically meaningful weight loss after four weeks and supporting further development in obesity and type 2 diabetes
doi: 10.1053/j.gastro.2023.06.036
Interestingly, the body weight of the CM combined with liraglutide group was significantly reduced compared with that of the sham group (Fig
